Health Trials

T-Cell/Histiocyte Rich Lymphoma

2

Review clinical trials related to T-Cell/Histiocyte Rich Lymphoma. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

SynKIR-310 for Relapsed/Refractory B-NHL

This first-in-human (FIH) trial is designed to assess the safety, feasibility and preliminary efficacy of a single intravenous (IV) dose of SynKIR-310 administered to participants with relapsed/refractory B-NHL.

Participants needed: 36
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Verismo TherapeuticsUpdated: Apr 14, 2026Locations: 5
Eligibility criteria

Adult 18 years of age and older. [+7]

Previously treated with any investigational agent within 30 days prior to screen... [+5]

Read more
Status: Recruiting

Study of SGR-1505 in Mature B-Cell Neoplasms

The purpose of this study is to evaluate safety and tolerability and to determine the maximum tolerated dose (MTD) or maximum administered dose (MAD) and/or recommended dose (RD) of SGR-1505.

Participants needed: 98
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Schrödinger, Inc.Updated: Feb 13, 2026Locations: 36
Eligibility criteria

Subject must have a history of histologically or cytologically confirmed mature... [+3]

The subject is in need of immediate cytoreductive therapy (unless the patient ha... [+4]

Read more